Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study

about

Alternate-day administration of S-1 for elderly patients with advanced non-small-cell lung carcinoma: A prospective feasibility study

Item

http://www.wikidata.org/entity/Q57788528

description

scientific article published on 24 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2018

@uk

name

Alternate-day administration o ...... prospective feasibility study

@en

Alternate-day administration o ...... prospective feasibility study

@nl

type

Item

label

Alternate-day administration o ...... prospective feasibility study

@en

Alternate-day administration o ...... prospective feasibility study

@nl

prefLabel

Alternate-day administration o ...... prospective feasibility study

@en

Alternate-day administration o ...... prospective feasibility study

@nl

P1476

Alternate-day administration o ...... prospective feasibility study

@en

P2093

Hironobu Hamada

http://www.w3.org/2001/XMLSchema#string

Hiroshi Iwamoto

http://www.w3.org/2001/XMLSchema#string

Kazunori Fujitaka

http://www.w3.org/2001/XMLSchema#string

Kosuke Hamai

http://www.w3.org/2001/XMLSchema#string

Masako Watanabe

http://www.w3.org/2001/XMLSchema#string

Mihoko Doi

http://www.w3.org/2001/XMLSchema#string

Noboru Hattori

http://www.w3.org/2001/XMLSchema#string

Nobuhisa Ishikawa

http://www.w3.org/2001/XMLSchema#string

Shinjiro Sakamoto

http://www.w3.org/2001/XMLSchema#string

Shintaro Miyamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for advanced non-small cell lung cancer in the elderly population

Cancer statistics, 2014

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

Alternate-day treatment with S-1 in patients with gastric cancer: a retrospective study of strategies for reducing toxicity.

Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.

Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo.

Multicenter, randomized, open-label Phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a first-line treatment in patients with unresectable advanced pancreatic cancer.

Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancer.

P304

539-544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2018.1705

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Taku Nakashima

Kakuhiro Yamaguchi

P577

2018-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30345049

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

Feasibility study

P932

6174452

http://www.w3.org/2001/XMLSchema#string